These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 22162978)
41. Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe. Simon TG; Corey KE; Chung RT; Giugliano R Dig Dis Sci; 2016 Dec; 61(12):3425-3435. PubMed ID: 27714510 [TBL] [Abstract][Full Text] [Related]
42. Nonalcoholic fatty liver disease as a multi-systemic disease. Fotbolcu H; Zorlu E World J Gastroenterol; 2016 Apr; 22(16):4079-90. PubMed ID: 27122660 [TBL] [Abstract][Full Text] [Related]
43. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. Streba LA; Vere CC; Rogoveanu I; Streba CT World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859 [TBL] [Abstract][Full Text] [Related]
44. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD. Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634 [TBL] [Abstract][Full Text] [Related]
45. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. Abenavoli L; Milic N; Di Renzo L; Preveden T; Medić-Stojanoska M; De Lorenzo A World J Gastroenterol; 2016 Aug; 22(31):7006-16. PubMed ID: 27610012 [TBL] [Abstract][Full Text] [Related]
46. Management of Cardiometabolic Complications in Patients With Nonalcoholic Fatty Liver Disease: A Review of the Literature With Recommendations. Dennis BB; Sallam S; Perumpail BJ; Shah ND; Kim D; Cholankeril G; Ahmed A J Clin Gastroenterol; 2021 Oct; 55(9):747-756. PubMed ID: 34469404 [TBL] [Abstract][Full Text] [Related]
47. Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications. Targher G; Byrne CD Semin Thromb Hemost; 2013 Mar; 39(2):214-28. PubMed ID: 23397556 [TBL] [Abstract][Full Text] [Related]
48. Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists? Ahmed MH; Barakat S; Almobarak AO J Obes; 2012; 2012():483135. PubMed ID: 23320150 [TBL] [Abstract][Full Text] [Related]
49. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986 [TBL] [Abstract][Full Text] [Related]
50. Dyslipidemia in patients with nonalcoholic fatty liver disease. Chatrath H; Vuppalanchi R; Chalasani N Semin Liver Dis; 2012 Feb; 32(1):22-9. PubMed ID: 22418885 [TBL] [Abstract][Full Text] [Related]
51. Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry. Younossi ZM; Yilmaz Y; Yu ML; Wai-Sun Wong V; Fernandez MC; Isakov VA; Duseja AK; Mendez-Sanchez N; Eguchi Y; Bugianesi E; Burra P; George J; Fan JG; Papatheodoridis GV; Chan WK; Alswat K; Saeed HS; Singal AK; Romero-Gomez M; Gordon SC; Roberts SK; El Kassas M; Kugelmas M; Ong JP; Alqahtani S; Ziayee M; Lam B; Younossi I; Racila A; Henry L; Stepanova M; Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2296-2306.e6. PubMed ID: 34768009 [TBL] [Abstract][Full Text] [Related]
52. Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis With Liver Fibrosis as Predictors of New-Onset Diabetes Mellitus in People With HIV: A Longitudinal Cohort Study. Han WM; Apornpong T; Lwin HMS; Thammapiwan S; Boonrungsirisap J; Gatechompol S; Ubolyam S; Tangkijvanich P; Kerr SJ; Avihingsanon A Clin Infect Dis; 2023 Dec; 77(12):1687-1695. PubMed ID: 37477514 [TBL] [Abstract][Full Text] [Related]